Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 Feb 28;2013(2):CD009974.
doi: 10.1002/14651858.CD009974.pub2.

Non pharmacological interventions for spasticity in multiple sclerosis

Bhasker Amatya  1 , Fary Khan, Loredana La Mantia, Marina Demetrios, Derick T Wade
Affiliations
Meta-Analysis

Non pharmacological interventions for spasticity in multiple sclerosis

Bhasker Amatya et al. Cochrane Database Syst Rev. .

Abstract

Background: Spasticity is commonly experienced by people with multiple sclerosis (MS), and it contributes to overall disability in this population. A wide range of non pharmacological interventions are used in isolation or with pharmacological agents to treat spasticity in MS. Evidence for their effectiveness is yet to be determined.

Objectives: To assess the effectiveness of various non pharmacological interventions for the treatment of spasticity in adults with MS.

Search methods: A literature search was performed using the Specialised Register of the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Review Group on using the Cochrane MS Group Trials Register which among other sources, contains CENTRAL, Medline, EMBASE, CINAHL, LILACS, PEDRO in June 2012. Manual searching in the relevant journals and screening of the reference lists of identified studies and reviews were carried out. Abstracts published in proceedings of conferences were also scrutinised.

Selection criteria: Randomised controlled trials (RCTs) that reported non pharmacological intervention/s for treatment of spasticity in adults with MS and compared them with some form of control intervention (such as sham/placebo interventions or lower level or different types of intervention, minimal intervention, waiting list controls or no treatment; interventions given in different settings), were included.

Data collection and analysis: Three review authors independently selected the studies, extracted data and assessed the methodological quality of the studies using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) tool for best-evidence synthesis. A meta-analysis was not possible due to methodological, clinical and statistical heterogeneity of included studies.

Main results: Nine RCTs (N = 341 participants, 301 included in analyses) investigated various types and intensities of non pharmacological interventions for treating spasticity in adults with MS. These interventions included: physical activity programmes (such as physiotherapy, structured exercise programme, sports climbing); transcranial magnetic stimulation (Intermittent Theta Burst Stimulation (iTBS), Repetitive Transcranial Magnetic Stimulation (rTMS)); electromagnetic therapy (pulsed electromagnetic therapy; magnetic pulsing device), Transcutaneous Electrical Nerve Stimulation (TENS); and Whole Body Vibration (WBV). All studies scored 'low' on the methodological quality assessment implying high risk of bias. There is 'low level' evidence for physical activity programmes used in isolation or in combination with other interventions (pharmacological or non pharmacological), and for repetitive magnetic stimulation (iTBS/rTMS) with or without adjuvant exercise therapy in improving spasticity in adults with MS. No evidence of benefit exists to support the use of TENS, sports climbing and vibration therapy for treating spasticity in this population.

Authors' conclusions: There is 'low level' evidence for non pharmacological interventions such as physical activities given in conjunction with other interventions, and for magnetic stimulation and electromagnetic therapies for beneficial effects on spasticity outcomes in people with MS. A wide range of non pharmacological interventions are used for the treatment of spasticity in MS, but more robust trials are needed to build evidence about these interventions.

PubMed Disclaimer

Conflict of interest statement

The review authors are clinicians in the field of Physical and Medical Rehabilitation and Neurology who wish to provide the best possible service to their patients. None have personal or financial conflicts of interest in the findings of this review.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Giovannelli 2007 {published data only}
    1. Giovannelli M, Borriello G, Castri P, Prosperini L, Pozzilli C. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clinical Rehabilitation 2007;21(4):331‐7. - PubMed
Lappin 2003 {published data only}
    1. Lappin MS, Lawrie FW, Richards TL, Kramer ED. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double‐blind, placebo controlled trial. Alternative Therapies in Health and Medicine 2003;9:38‐48. - PubMed
Miller 2007 {published data only}
    1. Miller L, Mattison P, Paul L, Wood L. The effects of Transcutaneous Electrical Nerve Stimulation (TENS) on spasticity in Multiple Sclerosis. Multiple Sclerosis 2007;13:527‐33. - PubMed
Mori 2010 {published data only}
    1. Mori F, Codeca C, Kusayanagi H, Monteleone F, Boffa L, Rimano A, et al. Effects of Intermittent Theta Burst Stimulation on spasticity in patients with Multiple Sclerosis. European Journal of Neurology 2010;17:295‐300. - PubMed
Mori 2011 {published data only}
    1. Mori F, Ljoka C, Magni E, Codeca C, Kusayanagi H, Monteleone F, et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. Journal of Neurology 2011;258(7):1281‐7. - PubMed
Nielsen 1996 {published data only}
    1. Nielsen JF, Sinkjaer T, Jakobsen J. Treatment of spasticity with repetitive magnetic stimulation; a double‐blind placebo‐controlled study. Multiple Sclerosis 1996;2(5):227‐32. - PubMed
Richards 1997 {published data only}
    1. Richards TL, Lappin MS, Acosta‐Urquidi J, Kraft GH, Heide AC, Lawrie FW, et al. Double‐blind study of pulsing magnetic field effects on multiple sclerosis. Journal of Alternative & Complementary Medicine 1997;3(1):21‐9. - PubMed
Schyns 2009 {published data only}
    1. Schyns F, Paul L, Finlay K, Ferguson C, Noble E. Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clinical Rehabilitation 2009;23(9):771‐81. - PubMed
Velkonja 2010 {published data only}
    1. Velikonja O, Curic K, Ozura A, Jazbec SS. Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clinical Neurology & Neurosurgery 2010;112(7):597‐601. - PubMed

References to studies excluded from this review

Bernhardt 2011 {published data only}
    1. Bernhardt L, Marziniak M. Specific resistance training for patients with multiple sclerosis. Multiple Sclerosis 2011;17:S465.
Castro‐Sanchez 2012 {published data only}
    1. Castro‐Sanchez AM, Mataran‐Penarrocha GA, Lara‐Palomo I, Saavedra‐Hernandez M, Arroyo‐Morales M, Moreno‐Lorenzo C. Hydrotherapy for the treatment of pain in people with Multiple Sclerosis: a randomized controlled trial.. Evidence‐Based Complementary and Alternatative Medicine 2012;[Epub ahead of print]:DOI: 10.1155/2012/473963. - PMC - PubMed
Chiara 1998 {published data only}
    1. Chiara T, Carlos J Jr, Martin D, Miller R, Nadeau S. Cold effect on oxygen uptake, perceived exertion, and spasticity in patients with Multiple Sclerosis. Archives of Physical Medicine & Rehabilitation 1998;79:523‐8. - PubMed
Farenelli 1999 {published data only}
    1. Farinelli M, Baratto L, Betti E, Morasso P Capra R, Spada G. Acupuncture improves postural control in patients with lower limbs spasticity: a randomized controlled trial. Giornale Italiano di Riflessoterapia ed Agopuntura 1999;11:71‐4.
Huges 2009 {published data only}
    1. Hughes CM, Smyth S, Lowe‐Strong AS. Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis 2009;15:1329‐38. - PubMed
Leocani 2012 {published data only}
    1. Leocani L, Nuara A, Formenti A, Rossi P, Zangen A, Comola M, et al. Deep rTMS with H‐Coil associated with rehabilitation enhances improvement of walking abilities in patients with progressive multiple sclerosis: randomized, controlled, double blind study. Neurology 2012;259(Suppl 1):S1–S236.
Livesley 1992 {published data only}
    1. Livesley E. Effects of electrical neuromuscular stimulation on functional performance in patients with Multiple Sclerosis. Physiotherapy 1992;78:914‐7.
Shaygannejad 2011 {published data only}
    1. Shaygannejad V, Ashtari F, Haghighi S, Vaezi A. The effect of Transcutaneous Electrical Nerve Stimulations on spasticity in Multiple Sclerosis patients in comparison with baclofen: a randomised single‐blinded clinical trial. Multiple Sclerosis 2011;17:S246.
Sosnoff 2009 {published data only}
    1. Sosnoff J, Motl RW, Snook EM, Wynn D. Effect of a 4‐week period of unloaded leg cycling exercise on spasticity in multiple sclerosis. Neurorehabilitation 2009;24:327‐31. - PubMed
Szecsi 2009 {published data only}
    1. Szecsi J, Schlick C, Schiller M, Pollmann W, Koenig N, Straube A. Functional electrical stimulation‐assisted cycling of patients with Multiple Sclerosis: biomechanical and functional outcome ‐ a pilot study. Journal of Rehabilitation Medicine 2009;41:674‐80. - PubMed

Additional references

Ansari 2008
    1. Ansari NN, Naghdi S, Hasson S, Azarsa MH, Azarnia S. The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Injury 2008;22(13‐14):1007‐12. - PubMed
Ansari 2009
    1. Ansari NN, Naghdi S, Hasson S, Fakhari Z, Mashayekhi M, Herasi M. Assessing the reliability of the Modified Modified Ashworth Scale between two physiotherapists in adult patients with hemiplegia. NeuroRehabilitation 2009;25(4):235‐40. - PubMed
Ashford 2010
    1. Ashford S, Turner‐Stokes L, Nair A. Poster 19: Psychometric evaluation of the Arm Activity Measure (ArmA) – A measure of active and passive function in the hemiparetic arm. Physical Medicine and Rehabilitation 2010;2(9 Suppl):S13‐4.
Ashworth 1964
    1. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540‐2. - PubMed
Beard 2003
    1. Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technology Assessment 2003;7:1‐111. - PubMed
Bhakta 1996
    1. Bhakta B, Coxens J, Bamford J, Chamberlain MA. Use of botulinum toxin in stroke patiens with severe upper limb spasticity. Journal of Neurology, Neurosurgery and Psychiatry 1996;61:30‐5. - PMC - PubMed
Bohannon 1987
    1. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy 1987;67(2):206‐7. - PubMed
Brashear 2002
    1. Brashear A, Gordon M, Elovic E, Kassicieh D, Marciniak C, Lee C, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. New England Journal of Medicine 2002;347(6):395‐400. - PubMed
Buetefisch 1995
    1. Buetefisch C, Hummelsheim H, Denzler P, Mauritz KH. Repetitive training of isolated movements improves the outcome of motor rehabilitation of the centrally paretic hand. Journal of Neurological Sciences 1995;130:59–68. - PubMed
De Paiva 1999
    1. Paiva A, Meuniere FA, Molgo J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proceedings of the National Academy of Sciences, United States of America. 1999; Vol. 16, issue 96:3200‐5. - PMC - PubMed
Demetrios 2012
    1. Demetrios M, Turner‐Stokes L, Brand C, McSweeney S, Khan F. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD009689] - DOI - PMC - PubMed
Egger 1998
    1. Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998;316(7124):61‐6. - PMC - PubMed
Goetzsche 1987
    1. Goetzsche PC. Reference bias in reports of drug trials. British Medical Journal 1987;295:654‐6. - PMC - PubMed
Green 2002
    1. Green J, Forster A. Reliability of gait speed measured by a timed walking test in patients one year after stroke. Clinical Rehabilitation 2002;16:306‐14. - PubMed
Harned 2011
    1. Harned ME, Salles SS, Grider JS. An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases. Pain Physician 2011;14(5):483‐9. - PubMed
Haselkorn 2005
    1. Haselkorn Jk, Little JW, Balsdon Richer CB, Miller JR, Fry‐Welch D, Herndon RM, et al. Spasticity management in Multiple Sclerosis. Journal of Spinal Cord Medicine 2005;28(2):167‐99. - PubMed
Henze 2006
    1. Henze T, Rieckmann P, Toyka KV. Symptomatic treatment of multiple sclerosis (Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society). European Neurology 2006;56:78–105. - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane‐handbook.org.
Hobart 2006
    1. Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, et al. Getting the measure of spasticity in multiple sclerosis: The Multiple Sclerosis Spasticity Scale (MSSS‐88). Brain 2006;129:224‐34. - PubMed
Kesiktas 2004
    1. Kesiktas N, Paker N, Erdogan N, Gülsen G, Biçki D, Yilmaz H. The use of hydrotherapy for the management of spasticity. Neurorehabilitation and Neural Repair 2004;18(4):268‐73. - PubMed
Khan 2007
    1. Khan F, Turner‐Stokes L, Ng L, Kilpatrick T, Amatya B. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD006036] - DOI - PMC - PubMed
Khan 2010
    1. Khan F, Gray O. Disability management and rehabilitation for persons with multiple sclerosis. Neural Regeneration Research 2010;5(4):301‐9.
Kurtzke 1983
    1. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33(11):1444‐52. - PubMed
Lance 1980
    1. Lance JW. Spasticity: disordered motor control. In: Feldman RG, Young RR, Koella WP editor(s). Symposium Synopsis. Chicago: Year Book Medical Publishers, 1980:485‐94.
Langhorne 2011
    1. Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet 2011;377(9778):1693‐702. - PubMed
Lockley 2006
    1. Lockley LJ, Buchanan K. Physical management of spasticity. In: Stevenson VL, Jarrett L editor(s). Spasticity Management: a Practical Multidisciplinary Guide. London: Informa Healthcare, 2006:37‐58.
Lublin 1996
    1. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46(4):907‐11. - PubMed
Lyle 1981
    1. Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. International Journal of Rehabilitation Research 1981;4:483‐92. - PubMed
Mahoney 1965
    1. Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Maryland State Medical Journal 1965;14:56‐61. - PubMed
Mc Donald 2001
    1. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001;50(1):121‐7. - PubMed
Mecomber 1971
    1. Mecomber SA, Herman RM. Effects of local hypothermia on reflex and voluntary activity. Physical Therapy 1971;51(3):271‐81. - PubMed
Mehrholz 2005
    1. Mehrholz J, Wagner K, Meissner D, Grundmann K, Zange C, Koch R, et al. Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study. Clinical Rehabilitation 2005;19:751‐9. - PubMed
Monaghan 2011
    1. Monaghan K, Horgan F, Blake C, Cornall C, Hickey PPM, Lyons BE, et al. Physical treatment interventions for managing spasticity after stroke. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD009188] - DOI
MS Australia 2009
    1. MS Australia. Spasticity and multiple sclerosis. MS Practice: June 2009; Vol. ISBN: 978‐0‐9806637‐4‐7.
Mukherjee 2010
    1. Mukherjee A, Chakravarty A. Spasticity mechanisms – for the clinician. Frontiers in Neurology 2010;149:1‐9. - PMC - PubMed
O'Dwyer 1996
    1. O'Dwyer NJ, Ada L. Reflex hyperexcitability and muscle contracture in relation to spastic hypertonia. Current Opinion in Neurology 1996;9(6):451‐5. - PubMed
Pandyan 2005
    1. Pandyan AD, Gregoric M, Barnes MP, Wood D, Wijck F, Burridge J, et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disability and Rehabilitation 2005;27(1‐2):2‐6. - PubMed
Penn 1989
    1. Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, et al. Intrathecal baclofen for severe spasticity. New England Journal of Medicine 1989;320(23):1517‐21. - PubMed
Pfleger 2010
    1. Pfleger CC, Flachs EM, Koch‐Henriksen N. Social consequences of multiple sclerosis (1): early pension and temporary unemployment‐‐a historical prospective cohort study. Multiple Sclerosis 2010;16:121‐6. - PubMed
Pfleger 2010a
    1. Pfleger CC, Flachs EM, Koch‐Henriksen N. Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study. Multiple Sclerosis 2010;16:878‐82. - PubMed
Podsiadlo 1991
    1. Podsiadlo D, Richardson S. The timed 'up and go': a test of basic functional mobility for frail elderly persons. Journal of the American Geriatrics Society 1991;39:142‐8. - PubMed
Polman 2005
    1. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of Neurology 2005;58(6):840‐6. - PubMed
Poser 1993
    1. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 1983;13(3):227‐31. - PubMed
Rekand 2010
    1. Rekand T. Clinical assessment and management of spasticity: a review. Acta Neurologica Scandinavica 2010;190:62‐6. - PubMed
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre,The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre,The Cochrane Collaboration, 2011.
Rietberg 2007
    1. Rietberg MB, Brooks D, Uitdehaag BMJ, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD003980.pub2] - DOI - PMC - PubMed
Rizzo 2004
    1. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Multiple Sclerosis 2004;10:589‐95. - PubMed
Robinson 1983
    1. Robinson BC. Validation of a Caregiver Strain Index (CSI). Journal of Gerontology 1983;38(3):344‐8. - PubMed
Shakespeare 2003
    1. Shakespeare D, Boggild M, Young CA. Anti‐spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD001332] - DOI - PubMed
Sheean 1998
    1. Sheean G. Pathophysiology of spasticity. In: Sheean G editor(s). Spasticity Rehabilitation. First Edition. London: Churchill Communications Europe LTD, 1998:17‐38.
Steins 2002
    1. Steins S, O'Young B, Young M. Person‐centred rehabilitation: interdisciplinary intervention to enhance patient enablement. In: O'Young B, Young M, Steins S editor(s). Physical Medicine and Rehabilitation Secrets. United States of America: Hanley & Belfus, 2002:4‐9.
Stevenson 2010
    1. Stevenson VL. Spasticity management. Clinical Rehabilitation 2010;24:293‐304. - PubMed
Turner‐Stokes 2011
    1. Turner‐Stokes L, Nair A, Sedki I, Disler PB, Wade DT. Multi‐disciplinary rehabilitation for acquired brain injury in adults of working age. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD004170.pub2] - DOI - PubMed
Van der Lee 2004
    1. Lee JH, Beckerman H, Knoll DL, Vet HC, Bouter LM. Clinimetric properties of the motor activity log for the assessment of arm use in hemiparetic patients. Stroke 2004;35:1410‐4. - PubMed
van Tulder 1997
    1. Tulder MW, Assendelft WJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the Cochrane Collaborations Back Review Group for Spinal Disorders. Spine 1997;22:2323‐30. - PubMed
Van Tulder 2003
    1. Tulder MW, Furlan A, Bombardier C, Bouter L. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003;28(12):1290‐9. - PubMed
Vickrey 1997
    1. Vickrey BG, Hays RD, Genovese BJ, Myers LW, Ellison GW. Comparison of a generic to disease‐targeted health‐related quality‐of‐life measures for multiple sclerosis. Journal of Clinical Epidemiology 1997;50(5):557‐69. - PubMed
Wade 2010
    1. Wade DT, Bovend’Eerdt TJH. How to set SMART goals. Clinical Rehabilitation 2010;24(4):382.
Weinshenker 1989
    1. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133‐46. - PubMed
WHO 2001
    1. World Health Organization. International Classification of Functioning Disability and Health (ICF). Geneva: WHO 2001.
WHO 2004
    1. World Health Organization. Atlas: country resources for neurological disorders. Programme for Neurological Diseases and Neuroscience, Geneva 2004.

Publication types

MeSH terms